Liposcience, Inc. (LPDX)

[surf1944]

8:05AM LipoScience guides Q2 revs in line with the low end of previous guidance, lowers FY13 rev guidance; appoints Robert Greczyn Interim President and CEO (LPDX) 6.43 : Co issues downside guidance for Q2 (Jun), sees Q2 (Jun) revs of $13.3 mln vs. $13.74 mln Capital IQ Consensus Estimate (Co said the $13.3 mln is in line with the low end of the guidance provided during the Company's first quarter 2013 earnings conference call).

Co issues lowered guidance for FY13 (Dec), sees FY13 (Dec) revs of $52-54 mln from prior guidance of $54-56 mln vs. $55.37 mln Capital IQ Consensus Estimate.

Co also announced that Richard Brajer has stepped down as President, CEO and Director to pursue other interests. Robert Greczyn has been named Interim President & Chief Executive Officer, effective immediately. The Board of Directors of LipoScience intends to initiate a search for a permanent CEO immediately.